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ScienceDirectMetabolism is at the heart of many biotechnologies from
biofuels to medical diagnostics. Metabolomic methods that
provide glimpses into cellular metabolism have rapidly
developed into a critical component of the biotechnological
development process. Most metabolomics methods have
focused on what is happening inside the cell. Equally important
are the biochemical transformations of the cell, and their effect
on other cells and their environment; the exometabolome.
Exometabolomics is therefore gaining popularity as a robust
approach for obtaining rich phenotypic data, and being used in
bioprocessing and biofuel development. Mass spectrometry
imaging approaches, including several nanotechnologies,
provide complimentary information by localizing metabolic
processes within complex biological matrices. Together, the
two technologies can provide new insights into the metabolism
and interactions of cells.
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Introduction
Diverse biotechnologies ranging from synthetic biology
to clinical research rely on an accurate understanding of
metabolism. Hence, metabolomics methods that charac-
terize and quantify the metabolic processes within the
cell have become integral to diverse research avenues.
Recently, metabolite imaging methods have been devel-
oped to localize metabolism within the biological matrix.
Now, exometabolomic methods are emerging to bridge
the gap between metabolic profiling and imaging experi-
ments.
Exometabolomics, also known as metabolic footprinting,
is the study of how cells transform their small molecule
environment. Here metabolomics is used to detectwww.sciencedirect.com changes in culture media as a result of cell culture,
typically, by comparing fresh versus spent media. While
simple, this approach provides powerful information on
cellular phenotypes while avoiding the challenges of
measuring intracellular metabolites. This is because exo-
metabolite levels integrate over minutes or hours versus
intracellular metabolites that may be altered or degraded
within milliseconds of extraction [1,2] requiring careful
quenching of ongoing cellular processes to minimize the
effects of cellular stresses encountered in sample prepa-
ration (e.g. centrifugation). Allen et al. in 2003 showed the
exometabolomics approach to be robust to sample prepa-
ration methods and could discriminate yeast growth states
and mutants using direct infusion electrospray ionization
(ESI) mass spectrometry [3]. More recently exometa-
bolomics has been used as an information-rich method
for studying released compounds under varying environ-
mental conditions [4], which will be discussed further
throughout this review.
Mass spectrometry is currently the principal method
used for exometabolomics [5], though other techniques
including NMR are also well suited for these studies
[5–7]. While direct infusion ESI enables high through-
put screening, liquid chromatography coupled to mass
spectrometry (LC–MS) greatly increases metabolite
coverage as chromatographic separation limits signal
suppression enabling detection of low-abundance or
weakly-ionizing metabolites (Figure 1a). A major limi-
tation of LC–MS exometabolomics is that it does
not provide information on the localization of these
metabolic processes.
Mass spectrometry imaging (MSI) enables direct interro-
gation of biomolecules within the 3D architecture of
cellular environments. This is accomplished by generat-
ing gas phase ions from spatially defined locations (e.g.
using a laser or focused ESI cone) ultimately to construct
a map of ions across a 2D surface. There are a wide-range
of MSI approaches, as recently reviewed [8,9] including
many nanotechnologies such as nanostructure-initiator
mass spectrometry (NIMS), Nan post Arrays (NAPA)
and many others [10].
Here we review exometabolomics approaches and appli-
cations to show how this simple technique can provide
critical insights into phenotypes, cellular interactions and
environmental transformations. We highlight how this
approach can be used in rapid phenotyping assays that
are becoming popular in drug development, syntheticCurrent Opinion in Biotechnology 2015, 34:209–216
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Illustration of exometabolomics workflows. (a) In LC–MS based exometabolomics, cells of interest are cultured in media containing metabolites,
and these metabolites are measured by LC–MS, before and after culture to define cellular substrates and products. (b) In MSI-based
exometabolomics, spatially defined desorption/ionization is used to generate images of metabolite composition across cell culture plates.biology, biofuel development, and investigating the met-
abolic interactions and dependencies of cells. Lastly, we
anticipate that exometabolomics in conjunction with
mass spectrometry imaging (MSI) will provide important
insights into metabolic interactions between populations
of cells.
Phenotypic analysis
The initial report describing metabolic phenotyping focused
on differentiating yeast strains using direct infusion. In this
study, the media from 19 Saccharomyces cerevisiae (yeast)
strains with unique deletions were compared, confirming
that gene knockouts can be discriminated reproducibly by
exometabolomic (AKA footprinting) measurements and sta-
tistical analysis [3]. There are many recent examples of
exometabolomic profiling in yeast. This was extended by
Chumnanpuen et al. to achieve real time sampling of yeast
media under three different growth conditions [11] and
Castrillo et al. used a systems biology approach, including
exometabolomics to understand the growth control of yeast
for metabolic engineering [12]. Another interesting applica-
tion is the recent comparison of 69 commercial yeast strains
commonly used in chardonnay production. Here, 29 primaryCurrent Opinion in Biotechnology 2015, 34:209–216 and secondary metabolites were measured, and up to 1000-
fold differences were noted between strains. The largest
variability was noted in the ratios of acetate esters to ethyl
esters, which greatly affects the sensory profile (predomi-
nantly taste) of wine [13].
We have used exometabolomics to investigate heterotro-
phy by the cyanobacterium, Synechococcus sp. PCC
7002 [14–16]. Here cultures were grown in four different
media: minimal media or the same augmented with yeast
extract or tissue culture media or extracts of Synechococcus
sp. PCC 7002. It was found that the cyanobacteria re-
leased very few metabolites but took up a wide range of
compounds. Interestingly, it appears that the cyanobac-
teria showed preference for their own metabolites includ-
ing many novel metabolites.
More recently we examined the use of this approach for
high throughput gene annotation using the complete
mutant libraries of Shewanella oneidensis MR1 [17] and
the KEIO Escherichia coli collection [18]. Here, exome-
tabolomics was used to identify 71 metabolites taken up
by the type strains. Ten interesting and commerciallywww.sciencedirect.com
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2.2 minute LC/MS method. Over 8000 mutants were
individually cultured in media augmented with these
10 metabolites for exometabolomic analysis, where failure
to take up a metabolite indicated disruption of an associat-
ed gene. This identified genes of known function, novel
transporters and enzymes including a histidase for
ergothionine [19], a microbial produced metabolite associ-
ated with Crohn’s disease [20]. Most recently, we have also
found that exometabolomics can be used for secondary
metabolite analysis from outer membrane vesicles
(OMVs), such as in the case of Myxococcus xanthus, which
secrete small molecules with antibiotic properties into
their extracellular environment [21].
Biofuel development
The use of lignocellulosic biomass for biofuel generation
has gained popularity in the last decade [22]. Lignocellu-
losic biomass is predominantly composed of cellulose,
hemicellulose and lignin. Lignin is a complex aromatic
polymer, which functions as the supportive structure of
lignocellulose. Currently, breakdown of lignocellulose
requires a pretreatment-hydrolysis step, in order to hy-
drolyze the rigid polysaccharides into monomers, for
microorganisms to utilize the biomass in fermentation
processes. This pretreatment, however, releases com-
pounds that can act as inhibitors of the fermentation
process, reducing the performance of fermenting yeast
[23]. Zha et al. used exometabolomics to identify novel
toxic inhibitors being released in the pretreatment step to
break down lignocellulose [24].
Microorganisms that are capable of mixed-sugar fermen-
tation are also used in the cellulosic biofuel industry, as
they have increased inhibitor tolerance. Casey et al. used
exometabolomics to monitor co-fermentation of glucose
and xylose in genetically engineered strains of yeast in the
presence of increasing salt concentration. They found
that xylose consumption was strongly affected by the
presence of salt, and a shift in metabolism to increased
glycerol production during xylose fermentation when salt
was present. It was concluded that salt concentrations
have a negative impact on yeast performance during
cellulosic ethanol production [25].
Bioprocesses
Microbes and mammalian cells are often used for indus-
trial production of complex protein therapeutics. Under-
standing what these specialized cells consume and
excrete can aid in designing processes to improve recom-
binant protein yields, folding properties, and desired
therapeutic activity [26]. Carinhas et al. looked at the
exometabolomic signatures of glutamine synthetase
(GS) — Chinese hamster ovary (CHO) clones to under-
stand the variable expression of IgG4, identifying re-
quired nutrients to increase IgG generation [6,27].
Carneiro et al. used exometabolomics to monitor thewww.sciencedirect.com metabolic impact of heterologous protein production in
E. coli. They noticed accumulation of glyoxylate shunt
pathway inhibitors in the culture media, and nutritional
shifts suggesting routes to replenish TCA cycle inter-
mediates required for the expression of heterologous
protein [28].
Other major bioprocessing applications for exometabolo-
mics have focused on increasing yields and for monitoring
fermentations. For example Xu et al. observed a 27%
increase in soluble sugars released from a glycogen
synthase null mutant in comparison with wild type Syne-
chococcus sp. [29]. Fu et al. used exometabolomics to
understand the impact of scale-up on the host microor-
ganism’s behavior during industrial fermentation [30].
Exometabolomics has also been used in bioprocess de-
velopment to monitor microbial contamination. Sue et al.
were able to accurately (97%) classify fermentation sam-
ples coming from contaminated cultures, using exome-
tabolomics with GC–MS [31].
Drug mechanisms of action
A recent development has been to use exometabolomics
to characterize the mechanism of action of an ethanolic
extract of Garcinia mangostana Linn. for the treatment of
malaria. Metabolites from the culture medium of the
malaria-causing parasite, Plasmodium falciparum, were
measured after treatment with the extracts. It was found
that these extracts resulted in the absence of malate in the
culture media which the authors attributed to interrup-
tion of TCA cycle metabolism in the parasite [32]. Un-
derstanding the mechanism of action of drugs through
exometabolomics is a promising research direction, which
could potentially be expanded to the investigation of drug
toxicity in the future (Figure 2).
Examining cellular interactions
While most articles and reviews published in the field of
exometabolomics describe LC–MS-based techniques
[38], laboratories have also been using mass spectrometry
imaging (MSI) as a complimentary technique that allows
for the localization of metabolites in 2D and 3D from
tissues [39–42], around biofilms and bacterial colonies
[8,9,35,36,43,44] among many other applications
[8]. MALDI and ESI-based techniques are most widely
used for metabolite MSI. While MALDI-MSI has the
advantage of being high throughput, ESI-based techni-
ques benefit from a more comprehensive analysis, due to
fewer metabolites being detected simultaneously. Addi-
tionally, nanometer-scale secondary ion mass spectrome-
try (nanoSIMS) has been widely used in conjunction with
stable isotopes to understand microbial metabolism and
the turnover of proteins and metabolites within tissues
and cells [45,46]. For example, Mayali et al. used nano-
SIMS to look at adaptations to nutrient availability in
mixed microbial communities within the San Francisco
Bay [47]. Similarly, Woebken et al. and Fike et al. used theCurrent Opinion in Biotechnology 2015, 34:209–216
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Approaches and technologies used for exometabolomics. (a) Protocol for preparation of exometabolites from liquid culture [14,33,34], and (b) two
protocols for preparation of exometabolites from agar gels [35,36,37].same technology to study N2 fixation and sulfide levels,
respectively, from the hypersaline microbial mats found
in Guerrero Negro, Baja California Sur, Mexico [48,49].
The Dorrenstein lab has developed a wide range of
approaches for imaging microbial interactions and second-
ary metabolites. Watrous et al. described the use of MALDI
imaging to map microbial exchange in three dimensions
(3D) [9]. They cut cross sections of 8 mm deep agar and
imaged each one. The images were computationally com-
bined to generate 3D models (see Figure 3d). These
models were able to map the chemical distributions of
Candida albicans in the presence of Pseudomonas aeruginosa,
and it was discovered that there was increased rhamnolipid
production by P. aeruginosa [9]. The Dorrenstein lab has
also published on a new concept describing the use of
nanospray desorption electrospray ionization (nanoDESI)
with MSI to profile metabolites directly from a Petri dish,
individually or in a mixed biofilm (Figure 3f) [50]. Addi-
tionally, Traxler et al. recently used MSI to study the
interaction between Streptomyces coelicolor with five actino-
mycetes (Figure 3e). They found that several desferriox-
amines were secreted by S. coelicolor while interacting with
several of the actinomycetes [37]. Essential data onCurrent Opinion in Biotechnology 2015, 34:209–216 secondary metabolites, including tandem mass spectrom-
etry data, is available via the Global Natural Products Social
Molecular Network (GnPS) (https://gnps.ucsd.edu/
ProteoSAFe/libraries.jsp). This database contains second-
ary metabolite spectra available for public searching from
multiple sources.
Nanostructure-initiator mass spectrometry is a highly
sensitive surface-based technique for metabolite analysis
from tissue sections [39,41,51,52]. However, early efforts
to extend this approach to investigate colony interactions
were unsuccessful largely due to microbial exopolysac-
charides that inhibited desorption/ionization. Recently,
the replica-extraction-transfer (REX) technique was de-
veloped to allow for the transfer of metabolites directly
from agar cultures onto nanostructure initiator mass spec-
trometry (NIMS) surfaces. These surfaces are advanta-
geous as they allow for the detection of small molecules
with very low background [43,51]. Acoustic printing of
bacteria allows for the growth of individual isolates in
close proximity (Figure 3a), and the sensitivity and spatial
resolution of NIMS allows for the detection of metabo-
lites both present on the bacteria, and in the surrounding
areas between bacterial isolates. The resulting data iswww.sciencedirect.com
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Examples of mass spectrometry imaging-based exometabolomics. (a) Acoustically printed bacteria imaged with NIMS, (b) the Web of Microbes
exometabolomics data repository for looking at microbial interactions and food webs [53], (c) the predatory behavior of M. xanthus in the
presence of E. coli [21], (d) three-dimensional MALDI imaging of P. aeruginosa and C. albicans in co-culture [9], (e) the interaction of
S. coelicolor with actinomycetes [37], and (f) MSI using nanoDESI directly from agar gels.
The part figure (b) is adapted with permission from Ref. [35] (Copyright 2014, American Chemical Society). The part figure (f) is adapted with
permission from Ref. [50] (Copyright 2013, American Chemical Society).directly accessible via the browser-based MSI software;
OpenMSI [36] (https://openmsi.nersc.gov/openmsi/
client/).
Outlook
Exometabolomic studies will provide critical insights into
the distributed metabolism occurring in microbial com-
munities and tissues by defining the metabolic inputs and
outputs of cell types. Given the importance of cell–cell
interactions including signaling and microenvironmental
controls, it is important to complement these studies with
MSI. Thus this integrated approach takes advantage of
the more comprehensive analysis of LC–MS/MS based
exometabolomics [8] and the spatial information provid-
ed by MSI. We envision that exometabolomic (e.g. webof-
microbes.com) [53], natural product (e.g. https://gnps.ucsd.
edu/ProteoSAFe/libraries.jsp), lipid (e.g. LipidMaps,
LipidBlast) [54,55], metabolite (e.g. Metlin, HMDB,
MassBank) [56–59] and MSI data repositories (e.g. Open-
MSI) will be critical to enable the integration of these
diverse data types and improvement of our understanding
of cellular metabolic interactions.www.sciencedirect.com A few recent examples illustrate the power of this ap-
proach for investigating microbial interactions, where one
microbe is releasing a substance that is toxic to a neigh-
boring microbe, such as is the case with the predatory
behavior seen by M. xanthus in the presence of E. coli
[21,60] (Figure 3c). Moree et al. investigated the interac-
tion between P. aeruginosa and Aspergillus fumigatus, com-
mon opportunistic pathogens in cystic fibrosis, at the
molecular level. They were able to visualize the secreted
metabolites through MALDI TOF and MALDI FT-ICR
based MSI, and it was discovered that secreted phena-
zines are converted by A. fumigatus into other chemical
entities with enhanced toxicities [61].
Conclusion
Exometabolomics provides an experimentally robust
approach to obtain rich phenotypic information on cells.
It has been used for diverse applications including gene
annotation, biofuel development, bioprocessing, and
drug mechanisms of action. This approach can be used
to define the inputs and outputs of cells to study cellular
interactions. While LC–MS is highly sensitive andCurrent Opinion in Biotechnology 2015, 34:209–216
214 Nanobiotechnologyprovides the largest dynamic range for characterization
of large numbers of metabolites, the localization of these
metabolites through MSI and targeted MSI provides
useful information for understanding how microbes
interact in complex environments.  The combination
of these two complementary  approaches, exometabolo-
mics and MSI, will provide critical information on the
distributed metabolism occurring in microbial and other
cellular communities.
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